| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
EX 527
|
49843-98-3 |
EX-527
|
EX 527;EX527;6-氯-2,3,4,9-四氢-1H-咔唑-1-甲酰胺;6-氯-2,9-四氢-1H-咔唑-1-羧酰胺;司来司他;SELISISTAT;EX 527;EX527;SEN0014196
|
C13H13CLN2O |
248.71 | |
|
IKK-16
|
873225-46-8 |
IKK-16,选择性IKK抑制剂
|
IKK-16,选择性IKK抑制剂;[4-[(4-苯并[B]噻吩-2-基-2-嘧啶)氨基]苯基][4-(1-吡咯烷)-1-哌啶基]-甲酮;CS-1847;IKK16;IKK-16;IKK INHIBITOR VII;1-[4-[(4-苯并[B]噻吩-2-基-2-嘧啶基)氨基]苯甲酰基]-4-(1-吡咯烷基)哌啶
|
C28H29N5OS |
483.62776 | |
|
3,4-dimethoxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]benzenesulfonamide
|
199666-03-0 |
RO 61-8048
|
3,4-二甲氧基-N-[4-(3-硝基苯基)-2-噻唑基]苯磺酰胺;3,4-二甲氧基-N-[4-(3-硝基苯)-噻唑]苯磺酰胺;3,4-二甲氧基-N-[4-(3-硝基苯基)-2-噻唑基]苯磺酰胺;CS-1828
|
C17H15N3O6S2 |
421.4475 | |
|
BRD4770
|
1374601-40-7 |
N/A
|
|
C25H23N3O3 |
413.46842 | 802-776-3 |
|
CB-839
|
1439399-58-2 |
CB-839
|
TELAGLENASTAT;CB-839,TELAGLENASTAT;CB839 ;CB 839 ;CB-839;CS-1813;CPD1593
|
C26H24F3N7O3S |
571.57407 | |
|
Verdinexor (KPT-335)
|
1392136-43-4 |
Verdinexor (KPT-335)
|
XPO1;CRM1抑制剂
|
C18H12F6N6O |
442.3178992 | -0 |
|
2,6-PYRIDINEDIAMINE, N6-[2-[[4-(2,4-DICHLOROPHENYL)-5-(1H-IMIDAZOL-1-YL)-2-PYRIMIDINYL]AMINO]ETHYL]-3-NITRO-
|
252935-94-7 |
CHIR98014(CT98014)
|
N6-[2-[[4-(2,4-二氯苯基)-5-(1H-咪唑-1-基)-2-嘧啶基]氨基]乙基]-3-硝基-2,6-吡啶二胺;CHIR 98014;CHIR98014;CHIR-98014;CHIR-98014;CHIR 98014;CT98014
|
C20H17Cl2N9O2 |
486.31408 | |
|
GSK2578215A
|
1285515-21-0 |
5-(2-氟-4-吡啶基)-2-(苯基甲氧基)-N-3-吡啶基苯甲酰胺
|
CS-1790;5-(2-氟-4-吡啶基)-2-(苯基甲氧基)-N-3-吡啶基苯甲酰胺;2-(苄氧基)-5-(2-氟吡啶-4-基)-N-(吡啶-3-基)苯甲酰胺
|
C24H18FN3O2 |
399.4232 | |
|
BAY 87-2243
|
1227158-85-1 |
BAY87-2243
|
CS-1786;BAY87 2243;BAY 87 2243;BAY87-2243
|
C26H26F3N7O2 |
525.5255496 | |
|
YK-4-279
|
1037184-44-3 |
YK 4-279
|
CS-1785;4,7-二氯-1,3-二氢-3-羟基-3-[2-(4-甲氧基苯基)-2-氧代乙基]-2H-吲哚-2-酮;YK-4-279;YK 4-279
|
C17H13NO4Cl2 |
366.19542 | |
|
URMC-099
|
1229582-33-5 |
URMC-099
|
3-(1H-吲哚-5-基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-1H-吡咯并[2,3-B]吡啶
|
C27H27N5 |
421.53678 | |
|
ISRIB (trans-isomer)
|
1597403-47-8 |
ISRIB(TRANS-ISOMER) 抑制剂
|
ISRIB (TRANS-ISOMER)>98%;ISRIB(TRANS-ISOMER)抑制剂
|
C22H24Cl2N2O4 |
451.34296 | |
|
ELR510444
|
1233948-35-0 |
ELR-510444
|
ELR510444>95%;CS-1765;ELR-510444;ELR510444;N-[5-(5-氰基-2-噻吩基)-2-甲基苯基]-4-甲基苯磺酰胺
|
C19H16N2O2S2 |
368.47254 | |
|
LB-100
|
1026680-07-8 |
3-(4-METHYLPIPERAZINE-1-CARBONYL)-7-OXABICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID
|
LB-100;LB-100, >95%;3-(1-methylpiperazine-4-carbonyl)-7-oxa-bicyclo[2.2.1]heptane-2-carboxylic acid;LB-100 3-(4-METHYLPIPERAZINE-1-CARBONYL)-7-OXABICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID;methyl 2,5-dimethyl-1-[(2-methylpropan-2-yl)oxycarbonylamino]pyrrole-3-carboxylate LB-100;LB-100, 1026680-07-8
|
C13H20N2O4 |
268.3089 | |
|
LY2584702
|
1082949-67-4 |
LY-2584702
|
CS-1752
|
C21H19F4N7 |
445.4221 | |
|
BMH-21
|
896705-16-1 |
BMH-21
|
CS-1749;BMH-21>98%;BMH 21;BMH21;N-[2-(二甲基氨基)乙基]-12-氧代-12H-苯并[G]吡啶并[2,1-B]喹唑啉-4-甲酰胺
|
C21H20N4O2 |
360.4091 | 809-833-1 |
|
Calpeptin
|
117591-20-5 |
CALPEPTIN
|
Z-LEU-NORLEUCINAL;N-BENZYLOXYCARBONYL-L-LEUCYL-NORLEUCINAL;((S)-4-甲基-1-氧代-1-(((S)-1-氧代己烷-2-基)氨基)戊-2-基)氨基甲酸苄酯
|
C20H30N2O4 |
362.46 | |
|
MHY1485
|
326914-06-1 |
MHY1485
|
MHY1485;4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine;4,6-Di-4-morpholinyl-N-(4-nitrophenyl)-1,3,5-triazin-2-amine
|
C17H21N7O4 |
387.39314 | |
|
PF-06447475
|
1527473-33-1 |
PF-06447475
|
PF-06447475>98%;CS-1734;PF 06447475;PF06447475;3-[4-(4-吗啉基)-7H-吡咯并[2,3-D]嘧啶-5-基]苯甲腈
|
C17H15N5O |
305.34 | |
|
CZC-54252
|
1191911-27-9 |
CZC-54252
|
CZC-54252, >98%;N-[2-[[5-Chloro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]methanesulfonamide hydrochloride;CZC-54252;N-(2-(5-chloro-2-(2-methoxy-4-morpholinophenylamino)pyrimidin-4-ylamino)phenyl)methanesulfonamide;CZC 54252 hydrochloride
|
C22H25ClN6O4S |
0 |
药智官方微信
药智官方微博
